GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » ROE % Adjusted to Book Value

Yunkang Group (HKSE:02325) ROE % Adjusted to Book Value : -4.02% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group ROE % Adjusted to Book Value?

Yunkang Group's ROE % for the quarter that ended in Jun. 2024 was -12.41%. Yunkang Group's PB Ratio for the quarter that ended in Jun. 2024 was 3.09. Yunkang Group's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -4.02%.

Yunkang Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Yunkang Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group ROE % Adjusted to Book Value Chart

Yunkang Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - - 5.17 -1.35

Yunkang Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.08 3.16 1.08 -4.26 -4.02

Competitive Comparison of Yunkang Group's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Yunkang Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yunkang Group's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Yunkang Group's ROE % Adjusted to Book Value falls into.


;
;

Yunkang Group ROE % Adjusted to Book Value Calculation

Yunkang Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4.35% / 3.23
=-1.35%

Yunkang Group's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-12.41% / 3.09
=-4.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yunkang Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Yunkang Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Yunkang Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
HKSE:06667 HKSE:09960 HKSE:08037 HKSE:02427 HKSE:08225 HKSE:08247 HKSE:00928 HKSE:09860 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA LH DGX
Traded in Other Exchanges
N/A
Address
No. 6 Yayingshi Road, Science City, Huangpu District, Guangzhou, CHN
Website
http://www.yunkanghealth.com
Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Kastle Limited 2301 Trustee
Yk Innovation Limited 2301 Trustee
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group Headlines

No Headlines